Heggie Theresa
Director at BCRX
- Sold, on record
- $1.1M
- Dollars the filings state
- Form 4 sales
- 3
- Latest Mar 20, 2026
- Form 144 notices
- 1
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- BCRXBIOCRYST PHARMACEUTICALS INCDirector
Sales by reason
0
Routine
0
Plan not stated
0
No plan
1
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice BCRXNoticeJun 14, 2024 2024
Filed to sell 6,698 shares ($41k)
Heggie Theresa, Director
No 10b5-1 planFirst sale on recordFiling
- 2 Form 4 sale BCRXNo planJun 14, 2024 same day
Sold 6,698 shares at $6.11 ($41k)
Heggie Theresa, Director
No 10b5-1 planSold 11.2% of holdings ($364k position)52,852 shares leftFirst sale on recordFollows a Form 144Filing
- 3 Form 4 sale BCRXUnusualAug 13, 2025 +425 days
Sold 70,000 shares at $8.51 ($596k)
Heggie Theresa, Director
No 10b5-1 planSold 51.7% of holdings ($1.2M position)65,352 shares leftFiling
- 4 Form 4 sale BCRXUnusualMar 20, 2026 +219 days
Sold 49,933 shares at $10.11 ($505k)
Heggie Theresa, Director
No 10b5-1 planSold 43.3% of holdings ($1.2M position)65,352 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 20, 2026 | Mar 24, 2026 | BCRX | Director | Form 4 sale | 49,933 | $505k | 43.3% | Unusual | SEC |
| Aug 13, 2025 | Aug 15, 2025 | BCRX | Director | Form 4 sale | 70,000 | $596k | 51.7% | Unusual | SEC |
| Jun 14, 2024 | Jun 14, 2024 | BCRX | Director | Form 4 sale | 6,698 | $41k | 11.2% | No plan | SEC |
| Jun 14, 2024 | Jun 14, 2024 | BCRX | Director | Form 144 notice | 6,698 | $41k | Notice | SEC |